NIH-funded research NIH-funded research

Understanding how tumors interact with the immune system

Official title: Project 2: Deciphering the Dynamic Evolution of the Tumor-Immune Interface

Funded at Massachusetts Institute of Technology · NIH-10930073 · Data updated 2026-11-12

This study is looking at how tumors and the immune system work together over time, with the goal of finding new ways to help patients fight cancer by improving their immune response.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMassachusetts Institute of Technology
NIH-funded
Lab location1 site (Cambridge, United States)
Project startSeptember 15, 2023
Project endAugust 31, 2028
Funding year2024
Award (this year)$422,043
NIH project number5U54CA283114-02
Project IDNIH-10930073 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include patients with glioblastoma or other cancers that exhibit immunosuppressive characteristics.

Less likely to help

Patients with non-cancerous conditions or those whose tumors do not interact significantly with the immune system may not benefit from this research.

What this research studies

This research investigates the complex interactions between tumors and the immune system, focusing on how these interactions evolve over time. By using advanced techniques to analyze molecular and cellular changes, the project aims to identify key pathways that contribute to tumor growth and resistance to therapies. Patients may benefit from insights gained through this research, which could lead to the development of new treatment strategies that enhance immune responses against tumors. The research employs both laboratory models and animal studies to validate findings and improve understanding of tumor-immune dynamics.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies that improve patient outcomes in cancer treatment.

How similar studies have gone: Previous research has shown promise in understanding tumor-immune interactions, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Massachusetts Institute of Technology
    Cambridge, United States
    Active

Researchers

  • Principal investigator: White, Forest M — Massachusetts Institute of Technology
  • Study coordinator: White, Forest M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.